Key Highlights
- General Mills delivered adjusted EPS of 64 cents, falling short of the 73-cent analyst forecast
- Net sales decreased 8% year-over-year to $4.44 billion, marginally exceeding the $4.41 billion consensus estimate
- Organic sales declined 3%, underperforming Nielsen-measured global retail sales by approximately 1.5 points
- The company maintained its full-year projections: organic sales decline of 1.5%–2%, adjusted profit decrease of 16%–20%
- GIS stock declined 0.8% in premarket trading, registering a 17% drop in 2026 and over 34% decline across the past 12 months
General Mills delivered a challenging fiscal third quarter performance on Wednesday, with earnings undershooting Wall Street expectations while sales barely exceeded analyst projections. The company maintained guidance previously revised downward last month — providing limited encouragement to shareholders.
Adjusted EPS registered at 64 cents, significantly below the 73 cents anticipated by analysts. Net sales, accounting for divestitures and acquisitions, contracted 8% year-over-year to $4.44 billion, marginally surpassing the $4.41 billion consensus forecast.
Organic sales decreased 3% — underperforming Nielsen-measured global retail sales by approximately 1.5 percentage points. This performance gap indicates General Mills faces market share erosion beyond broader economic challenges.
Shares declined 0.8% in premarket trading after the earnings release. Prior to Wednesday’s report, GIS had already declined 17% in 2026 and more than 34% over the trailing 12 months, positioning it among the weakest performers in the packaged food sector.
Price-Conscious Shoppers Drive Private Label Growth
The underlying dynamic remains straightforward. Budget-conscious consumers facing elevated costs increasingly select private-label and store-brand alternatives over established brands like Cheerios, Lucky Charms, and Pillsbury.
This transition has gained momentum over recent quarters. Packaged food companies that relied heavily on price increases during the inflationary period now face significant headwinds. General Mills confronts the same challenge.
Beyond pricing dynamics, dietary trends continue shifting away from processed and packaged foods. The rapid expansion of GLP-1 weight-loss medications has intensified this pressure, influencing consumers to modify their eating patterns.
Uncertainty surrounding consumer spending — partially linked to geopolitical tensions including the Iran war — has created additional headwinds for demand in the pantry staples category.
Company Maintains Previously Reduced Annual Guidance
General Mills kept its full-year projections intact, though these forecasts had already been lowered last month. The company continues to anticipate organic net sales will decline 1.5% to 2% for the fiscal year.
Adjusted operating profit and adjusted earnings remain projected to decrease 16% to 20% in constant currency. This represents a substantial decline, which the market has been incorporating into valuations for several months.
The guidance reaffirmation offered limited reassurance to investors. With organic sales underperforming retail measurements and the earnings miss compounding an already difficult period, Wednesday’s report provided few catalysts for sentiment improvement.
The S&P 500 futures were up 0.4% on Wednesday, with the benchmark index down 1.9% so far in 2026.
